Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Actos bladder cancer trial scheduled for February 2013

Filed November 13th, 2012 Joshua Sophy

One of the first lawsuits in which someone claims that taking the type 2 diabetes drug Actos resulted in them developing bladder cancer is set to go to trial early next year.

According to an announcement from the national law firm of Parker Waichman LLP, a judge in California Superior Court has set a trial date for Feb. 19, 2013 in the case involving a Mississippi man, Jack Cooper, who claims he took Actos and then developed a life-threatening case of bladder cancer.

Cooper is one of thousands of people who have may have contracted bladder cancer as a result of taking Actos in the treatment of their type 2 diabetes. His lawsuit is among the first in the country to reach the trial phase and the results of it could weigh heavily on the fate of potentially 10,000 more lawsuits filed in courts across the country.

Parker Waichman LLP is currently involved in a leadership role with a growing federal Multidistrict Litigation that represents about 2,500 people who believe they acquired bladder cancer or were put at risk of the disease because they took Actos. Further, the lawsuits claim that Takeda Pharmaceuticals knowingly hid the dangerous side effects of its top-selling drug. Jerrold Parker, the founding partner of the law firm, has been appointed to serve on the Plaintiffs’ Steering Committee in the MDL.

More and more evidence is pointing to the dangers of Actos and many countries around the world have acted to restrict access to the drug, including banning its sale altogether. A recent study published in a Canadian medical journal suggests that people taking Actos for longer than a year are at a 22 percent greater risk of developing bladder cancer than people taking another diabetes drug.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!